Latest News for: interleukin 6

Edit

The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion Proteins, Monoclonal antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Disorders, and Oncology | DelveInsight

PR Newswire 27 Mar 2025
Learn more about the IL-2 treatment landscape @ Interleukin-2 Therapeutic Landscape ... To know more about FDA-approved IL-2 inhibitors, visit @ Approved Interleukin-2 Drugs ... @ Interleukin-2 Market Report.
  • 1
×